Protagenic Therapeutics (PTIX) — Net Asset Quality Index
Protagenic Therapeutics (PTIX) has a Net Asset Quality Index of -220.1% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $2.13 Million minus total liabilities of $6.82 Million yields net assets of $-4.69 Million. A higher index indicates a stronger, lower-leverage balance sheet. See Protagenic Therapeutics (PTIX) defensive interval to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Protagenic Therapeutics Net Asset Quality Index Over Time (1995–2025)
This chart shows how Protagenic Therapeutics's Net Asset Quality Index has evolved across 30 annual periods from 1995 to 2025. As of December 2025, the index stands at -220.1%, representing net assets of $-4.69 Million against total assets of $2.13 Million USD. Explore PTIX cash flow metrics to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Protagenic Therapeutics (1995–2025)
The table below presents the year-by-year Net Asset Quality Index for Protagenic Therapeutics from 1995 to 2025, covering 30 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see PTIX market cap overview.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | -220.1% | $-4.69 Million | $2.13 Million | $6.82 Million | ▼ -271.9 pp |
| 2024 | 51.8% | $1.01 Million | $1.96 Million | $942.76K | ▼ -33.0 pp |
| 2023 | 84.8% | $3.67 Million | $4.32 Million | $655.25K | ▼ -1.2 pp |
| 2022 | 86.1% | $6.92 Million | $8.04 Million | $1.12 Million | ▼ -3.8 pp |
| 2021 | 89.9% | $9.94 Million | $11.06 Million | $1.12 Million | ▲ +220.7 pp |
| 2020 | -130.8% | $-1.15 Million | $879.25K | $2.03 Million | ▼ -55.4 pp |
| 2019 | -75.3% | $-634.37K | $842.27K | $1.48 Million | ▼ -45.1 pp |
| 2018 | -30.3% | $-210.88K | $696.88K | $907.77K | ▼ -98.7 pp |
| 2017 | 68.5% | $1.22 Million | $1.78 Million | $561.69K | ▼ -9.9 pp |
| 2016 | 78.3% | $2.48 Million | $3.16 Million | $684.86K | ▲ +507.7 pp |
| 2015 | -429.3% | $-571.00K | $133.00K | $704.00K | ▼ -55.6 pp |
| 2015 | -373.7% | $-497.00K | $133.00K | $630.00K | ▼ -345.2 pp |
| 2014 | -28.5% | $-70.00K | $246.00K | $316.00K | ▲ +0.0 pp |
| 2013 | -28.5% | $-70.00K | $246.00K | $316.00K | ▲ +1777.2 pp |
| 2012 | -1805.7% | $-17.23 Million | $954.00K | $18.18 Million | ▼ -1847.9 pp |
| 2010 | 42.3% | $8.17 Million | $19.34 Million | $11.17 Million | ▼ -14.6 pp |
| 2009 | 56.8% | $25.35 Million | $44.60 Million | $19.25 Million | ▼ -12.5 pp |
| 2008 | 69.4% | $54.65 Million | $78.76 Million | $24.11 Million | ▼ -1.0 pp |
| 2007 | 70.4% | $16.86 Million | $23.96 Million | $7.10 Million | ▲ +48.1 pp |
| 2006 | 22.3% | $1.22 Million | $5.49 Million | $4.27 Million | ▼ -17.1 pp |
| 2004 | 39.4% | $2.74 Million | $6.95 Million | $4.21 Million | ▲ +3.1 pp |
| 2003 | 36.2% | $4.98 Million | $13.74 Million | $8.76 Million | ▼ -23.6 pp |
| 2002 | 59.8% | $12.87 Million | $21.53 Million | $8.65 Million | ▲ +1.5 pp |
| 2001 | 58.3% | $13.57 Million | $23.27 Million | $9.71 Million | ▼ -2.2 pp |
| 2000 | 60.5% | $13.86 Million | $22.92 Million | $9.06 Million | ▲ +2.6 pp |
| 1999 | 57.9% | $13.27 Million | $22.93 Million | $9.66 Million | ▼ -7.1 pp |
| 1998 | 64.9% | $13.95 Million | $21.48 Million | $7.53 Million | ▼ -19.4 pp |
| 1997 | 84.3% | $13.30 Million | $15.77 Million | $2.47 Million | ▲ +28.3 pp |
| 1996 | 56.0% | $7.04 Million | $12.57 Million | $5.53 Million | ▼ -11.8 pp |
| 1995 | 67.8% | $7.51 Million | $11.08 Million | $3.57 Million | — |